AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05742763 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Acetaminophen and PRP
Description: The primary research purpose is to determine if the use of ibuprofen \[arm #1\] vs acetaminophen \[arm #2\] vs a placebo control group \[arm #3\] with the intervention of a series of three injections of LP-PRP into the knee joint, leads to significantly greater reductions in average knee pain severity, and increases in physical function and quality of life, in patients with symptomatic moderate KOA, and grade 2 or 3 radiographic changes defined by the Kellgren-Lawrence (K-L) classification system.
Study NCT05742763 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo and PRP
Description: The primary research purpose is to determine if the use of ibuprofen \[arm #1\] vs acetaminophen \[arm #2\] vs a placebo control group \[arm #3\] with the intervention of a series of three injections of LP-PRP into the knee joint, leads to significantly greater reductions in average knee pain severity, and increases in physical function and quality of life, in patients with symptomatic moderate KOA, and grade 2 or 3 radiographic changes defined by the Kellgren-Lawrence (K-L) classification system.
Study NCT05470283 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OBX-115
Description: Given by IV
Study NCT05470283 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Description: Given by PO
Study NCT05470283 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Given by IV
Study NCT05470283 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Furosemide
Description: Given by IV
Study NCT05470283 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mesna
Description: Given by IV
Study NCT05470283 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine Phosphate
Description: Given by IV
Study NCT05730751 — intervention group
Intervention type: PROCEDURE
Intervention: spinal anesthesia
Description: spinal anesthesia
Study NCT06000774 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Therapeutic Ketogenic Diet
Description: therapeutic ketogenic diet
Study NCT06359288 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group receiving QR code supported training
Description: During the training process, QR codes were integrated into the sections related to the care of the newborn in the guide to provide mothers with the opportunity to watch the video simultaneously while reading the guide in practices requiring skills related to hygienic care of the newborn and nutrition / communication / sleep, and to allow them to watch it repeatedly as long as they feel the need. In these videos, the application steps were shown one by one. When the code is scanned with a smartphone, it automatically redirects the user to the specified URL. The QR codes in the Implementation Guide on the Care of the Newborn consist of eight videos) that allow mothers to watch the hygienic care of the newborn in practice. After the end of this phase of the training, the questionnaires were re-administered to the mothers in both groups one month after discharge.
Study NCT06259188 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Respiratory Muscle Training Device
Description: In the both groups the initial pressure load will be set to the resistance level corresponding to the 40% of the MIP and MEP measurement. Participants will be asked to rest following 5 breathing cycles and repeat the training for 10 sets. In each set, there will be a one-minute rest break between repetitions. In breathing exercise device group participants will be able to practice both inspiratory and expiratory respiratory muscle training in a single breathing cycle. In IMT+EMT group, patients will be able to practice different to device. As the progression progresses, the perceived exertion level will be increased by 5-10% every week, to be in the range of 4-6 according to the Modified Borg scale.
Study NCT06259188 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Personalized Breathing Exercise Device
Description: Personalized Breathing Exercise Device
Study NCT05730751 — intervention group
Intervention type: PROCEDURE
Intervention: caesarean section
Description: LSCS
Study NCT04941183 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NTR-441
Description: NTR-441
Study NCT04941183 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05229380 — intervention group
Intervention type: DRUG
Intervention: Saccharin test
Description: Saccharin is a nonnutritive sweetener. It has property of being inert to respiratory epithelium that is it does not hamper physiological mucus clearance of sino-nasal mucosa. Methylene blue is a chemical compound. It can be used to check patency of (ET). The dye, because of its liquid form, gravitates through the ET to the nasopharynx.
Study NCT05369728 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Coronary CT in 1st line compared to the strategy with functional test in 1st line in patient at Intermediate Risk of Developing Stable Coronary Disease:
Description: Coronary CT in 1st line compared to the strategy with functional test in 1st line in Patients at Intermediate Risk of Developing Stable Coronary Disease:
Study NCT05399056 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Telephonic Peer Coaching
Description: Telephonic Peer Coaching from an individual with lived experience with COPD and Pulmonary Rehabilitation trained in motivational interviewing
Study NCT05399056 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Storytelling
Description: Video narratives of an individual with lived experience with COPD and Pulmonary Rehabilitation describing their journey through Pulmonary Rehabilitation
Study NCT05080036 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Medio-lateral imbalance
Description: Thrust on the pelvis in the medio-lateral direction in order to create a balance perturbation
Study NCT05609734 — intervention group
Intervention type: OTHER
Intervention: no intervention, only observational retrospective study
Description: no intervention, only observational retrospective study
Study NCT05180201 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Synbiotic
Description: Lactiplantibacillus plantarum ATCC 202195 with fructooligosaccharide
Study NCT05180201 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: Lactiplantibacillus plantarum ATCC 202195
Study NCT05180201 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Maltodextrin
Study NCT05180201 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Maltodextrin
Study NCT04918589 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: 3 grams of tranexamic acid (30 mL of 100 mg/mL solution) diluted in 10 mL of normal saline
Study NCT04918589 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal Saline
Description: 40 mL topical of 0.9% normal saline
Study NCT05623618 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PACE labelling
Description: PACE labelling implemented near at least one discretionary food item in secondary school canteens for up to 6 weeks.
Study NCT06045858 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anticoagulation Agents
Description: anticoagulation in peritoneal dialysis patients with non valvular atrial fibrillation during one year
Study NCT04924257 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray
Description: Patients will receive two treatments per week for four weeks (maximum of eight treatment sessions) or until clinical remission (MADRS \<10).
Study NCT04924257 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Electroconvulsive therapy
Description: Patients will receive three treatments per week for four weeks (maximum of 12 ECT treatments) or until clinical remission (MADRS \<10).
Study NCT06045858 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anticoagulation Agents
Description: anticoagulation in peritoneal dialysis patients with non valvular atrial fibrillation during one year
Study NCT05390905 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HSK21542 Injection
Description: 1μg/kg/dose
Study NCT05390905 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol hydrochloride
Description: 50mg/dose
Study NCT05390905 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study NCT05925699 — intervention group
Intervention type: OTHER
Intervention: Collection of clinical, radiological, and biological data from patients' medical records
Description: Collection of clinical, radiological, and biological data from patients' medical records
Study NCT05375656 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cross-over study
Description: Traditional Inuit Diet and Western Diet.
Study NCT05375656 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cross-over study
Description: Traditional Inuit Diet and Western Diet.
Study NCT05487976 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Recombinant human activated coagulation factor VII for injection
Description: Human coagulation factor VII is a vitamin K-dependent serine endogenous protease, and its activated form plays an important role in the coagulation process. Recombinant human activated coagulation factor VII is an activated state coagulation factor VII obtained by recombinant means.
Study NCT05962645 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vapendavir
Description: This study will measure and compare how VPV is absorbed in the blood, broken down in the body and eliminated when two 250 mg VPV tablets (500mg) are given in three different ways: A single dose, once a day, under fasted conditions (without any food); twice a day, for 7 days; and a single dose, once a day under fed conditions, after consuming a high-fat meal.
Study NCT06166342 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo sachet
Description: Consume 1 sachet daily
Study NCT06166342 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: TCI153 probiotic sachet
Description: Consume 1 sachet daily
Study NCT05177302 — intervention group
Intervention type: OTHER
Intervention: HAGOS-C
Description: The subjects will be instructed to complete HAGOS-C at the initial contact and again after 1 week and 4 month for reliability and responsiveness test, respectively
Study NCT05177302 — intervention group
Intervention type: OTHER
Intervention: SF-36v2
Description: The subjects will be instructed to complete SF-36v2 at the initial contact to determine the validity of HAGOS-C
Study NCT04724291 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: MAGNET
Description: This study will test the accuracy of a single-use ingestible video capsule (NaviCamTM, AnX Robotica) which is remotely controlled to record images of the inside of your stomach. Participants in this research study will have symptoms for which an evaluation by a traditional tube-based endoscopy (EGD) is indicated.
Study NCT06185686 — intervention group
Intervention type: OTHER
Intervention: Cognitive testing
Description: NIH Toolbox Cognitive Battery and the Novel Cognitive Measure (NCM)
Study NCT06185686 — intervention group
Intervention type: DEVICE
Intervention: Resting State MRI/Precision functional mapping
Description: At baseline (before the end of radiation therapy) and approximately 12 months after the completion of radiation therapy.
Study NCT05817591 — intervention group
Intervention type: OTHER
Intervention: Questionnaires
Description: In current practice, capsaicin patch treatment is offered to patients with a 24-hour average pain level measured by the EN numerical scale : EN scale is > 4 Pain monitoring questionnaires will be completed by patients every 6 weeks : Neuropathic Pain Symptom Invetory (NPSI Score), Patients' Global Impression of Change (PGIC scale), Numerical pain scale
Study NCT04935190 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Vitalpercept
Description: Comparison of resting heart and respiratory rate measurements acquired by contactless radar sensors, electrocardiography, and capnography
Study NCT04614194 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Letrozole
Description: Oral. Tablets should be taken at the same times every day, with or without food.
Study NCT04734600 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Electronic Treadmill device
Description: group A:PN-7001M Panasonic Treadmill 130 kg, frequency 50 HZ, input voltage AC220 V, input power 100W+_ 10 will usefor aerobic training program ,start by 1pbm grading to 2pbm speed and increase according to patient abilities during sessions ,0% treadmill inclination angle for two month as a total treatment period for study group patients.~Patients in this group will participate in aerobic training as march walking on treadmill for 45 mints duration for session 3 times per week, start with 5 mints warm up beginning and 5 mints cooling down at end session, in addition to their medical program and burger exercises
Study NCT04734600 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: myofascial release technique
Description: group B:The myofascial release technique group will receive a 45 mints session time, for3 times per week for two months in addition to their medical program and burger exercises. Before the MF will starte, patient will rested in a relaxed prone position for 15 to 30 mints and also after end session time, MF protocol will applied as follow sequence over all period of total treatment sessions (8) week.:~thoracolumbar cross hand facial release technique for at least 5 mints for every barrier depth area, started by one hand will place on high thoracic area with pressure applied cephalic, the other hand was placed directly on the lower lumbo -sacrum area pushing caudal and arms are crossed to maximize as leverage as the barrier sense of softening will occurre and release sense on fascia under hand (release done at transverse alternative with longitudinal direction)alternation same methods to affected leg
Study NCT05852561 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group Superficial+Deep Serratus Anterior Plan Block
Description: The block will be performed after induction of general anesthesia and surgical positioning. 15 ml of 0.375% Bupivacaine + epinephrine 5 µg/ml will be administered between the serratus anterior and latissimus dorsalis muscles. The same concentration of block fluid will be applied between the serratus anterior and the outer intercostal muscle.
Study NCT05852561 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group Deep Serratus Anterior Plan Block
Description: 30 ml 0.375% Bupivacaine + epinephrine 5 µg/ml will be administered between the serratus anterior and outer intercostal muscle.
Study NCT06338124 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Triglyceride glucose index
Description: To evaluate the role of various laboratory biomarkers ( TyG , RAR , CAR, N\\L ratio, CRP, Serum lactate )in prediction of sepsis outcome.
Study NCT04614194 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Abemaciclib
Description: Oral. Tablets should be taken at the same times every day, with or without food.
Study NCT05849389 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vosoritide
Description: Vosoritide administered daily via subcutaneous injection for 12 months using the FDA approved weight-based dosing band strategy for achondroplasia.
Study NCT05764759 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking cessation e-visit
Description: electronic visits (e-visits) for smoking cessation
Study NCT05764759 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual
Description: Information about the state quitline and about the importance of quitting smoking and a recommendation to contact one's PCP to schedule a medical visit to discuss quitting smoking.
Study NCT05389631 — intervention group
Intervention type: OTHER
Intervention: no intervention
Description: no intervention
Study NCT04990427 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CLBS201
Description: 1 x 10\^6 to 300 x 10\^6 autologous CD34+ cells
Study NCT05571865 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Probiotic
Description: Oral administration of a probiotic
Study NCT04939376 — intervention group
Intervention type: PROCEDURE
Intervention: IVF
Description: In vitro fertilization
Study NCT04730648 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PCSK9 inhibitor
Description: For newly diagnosed ACS patients with diabetes, multivessel occlusion, or recurrent ACS attack, who are willing to accept PCSK9 inhibitor injection.
Study NCT05923827 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Omnipod 5 System
Description: The Omnipod 5 system is a tubeless patch pump that receives glucose values and trend data from the glucose sensor every 5 minutes, automatically calculates insulin dose, and sends delivery commands to the Pod for the delivery of insulin.
Study NCT06384313 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: butyrate/hexanoate-enriched triglycerides
Description: The oils are consumed two times a day for 24 weeks (six months).
Study NCT06384313 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: butyrate/hexanoate-enriched triglycerides
Description: The oils are consumed two times a day for 24 weeks (six months).
Study NCT05623033 — intervention group
Intervention type: OTHER
Intervention: The study is an observational study without intervention
Description: The study is an observational study without intervention
Study NCT05340231 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TACE protocol
Description: Transarterial infusion chemotherapy: Oxaliplatin(85mg/m\^2)+Raltitrexed(3mg) Chemoembolization: Lipiodol emulsion (lipiodol 10ml+ Oxaliplatin 85mg +Lidocaine 1ml)，The endpoint for embolization was defined as stagnation of blood flow of the posterior mesenteric artery.~Intervention cycle：4W; Treatment times: 2. followed by mFOLFOX6
Study NCT05340231 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neoadjuvant Chemotherapy
Description: mFOLFOX6, Q2W
Study NCT04975087 — intervention group
Intervention type: OTHER
Intervention: Patients group
Description: Patients will complete the mentioned questionnaires.
Study NCT05467813 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: mirror therapy
Description: The mirror therapy (MT) will be done with participants seated at a table. The affected upper-extremity (UE) will be placed behind the mirror and the unaffected UE in front of the mirror. Participants will be asked to do the same movements using both the unaffected and affected UE as possible. Each participant will practice two different MT protocols: unilateral mirror therapy (UMT) and bilateral mirror therapy (BMT). During UMT, the affected hand is static, while during BMT, the affected hand moves in an attempt to duplicate the unaffected hand as best as possible. The MT activities include gross motor movements, fine motor movements, and object manipulation.
Study NCT05467813 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: mirror therapy
Description: The mirror therapy (MT) will be done with participants seated at a table. The affected upper-extremity (UE) will be placed behind the mirror and the unaffected UE in front of the mirror. Participants will be asked to do the same movements using both the unaffected and affected UE as possible. Each participant will practice two different MT protocols: unilateral mirror therapy (UMT) and bilateral mirror therapy (BMT). During UMT, the affected hand is static, while during BMT, the affected hand moves in an attempt to duplicate the unaffected hand as best as possible. The MT activities include gross motor movements, fine motor movements, and object manipulation.
Study NCT05379933 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Remote health coaching to improve self-care behaviors
Description: Participants will be asked to wear an activity tracker, complete brief surveys, and participate in weekly health coaching sessions remotely for 8 weeks
Study NCT04849195 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT04778644 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBD
Description: Oral gel capsule CBD
Study NCT06097078 — intervention group
Intervention type: DEVICE
Intervention: Eso-SPONGE®
Description: minimally invasive treatment and prevention of anastomotic leakages and perforations in the upper gastrointestinal tract (upper GIT)
Study NCT05467813 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: augmented reality (AR)
Description: The training program provides goal-directed exercises designed to be adjustable in order to match the patient's ability to minimize compensatory movements. To ensure safety, the investigators will place a handrail in front of the participant for support. The goal-directed exercise includes balance training (i.e., weight shifting, standing on one leg), activities of daily living training (i.e., reaching), and cognitive enhancement (i.e., memory training). By using the AR system, participants can observe the real performance of motions and interaction between the body and the virtual environment.
Study NCT05467813 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: augmented reality (AR)
Description: The training program provides goal-directed exercises designed to be adjustable in order to match the patient's ability to minimize compensatory movements. To ensure safety, the investigators will place a handrail in front of the participant for support. The goal-directed exercise includes balance training (i.e., weight shifting, standing on one leg), activities of daily living training (i.e., reaching), and cognitive enhancement (i.e., memory training). By using the AR system, participants can observe the real performance of motions and interaction between the body and the virtual environment.